Anta is an associate at Sofinnova Partners since 2017. She obtained her PhD in Clinical Medical Research from the National Heart and Lung Institute at Imperial College in London, in collaboration with Pfizer, where she worked on elucidating the mechanisms by which oxidative stress drives corticosteroid insensitivity in COPD. She conducted her post-doctoral training at the French National Institute of Health and Medical Research (INSERM) on immune regulation of the cardiac contractile machinery and function post myocardial infarction. Anta holds a 1st class BSc in Molecular Biology from University of Liverpool, UK. Prior to joining Sofinnova Partners, she was an Immunology Scientist in the Life Sciences Division of Danone Nutricia Research.